Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long Is Long Enough?

Authors
Category Primary study
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2019
In a multicenter, observational, propensity-score-weighted cohort of 249 adults with uncomplicated Pseudomonas aeruginosa bacteremia, patients receiving short-course (median, 9 days; interquartile range [IQR], 8-10) therapy had a similar odds of recurrent infection or death within 30 days as those receiving longer courses (median, 16 days; IQR, 14-17).
Epistemonikos ID: 511da65013c3e6fde4d957d04f8af809bb76272e
First added on: Jun 03, 2021